2016 Spirit of Small Business Awards winners announced
The Pacific Coast Business Times is pleased to announce our 2016 class of Spirit of Small Business Awards winners. This annual special section, now in its 14th year, celebrates small-business ownership and entrepreneurship in the Tri-Counties. The report published with the July 22 print edition. The winners will be honored at an awards luncheon on Friday, August 19 at Bacara Read More →
Read More →Amgen settles lawsuit, says biosimilar works as well as Herceptin
Amgen settled a lawsuit and released positive news about a breast cancer biosimilar this week. The Thousand Oaks-based biotech giant said July 20 the company reached a settlement stemming from a class action lawsuit involving shareholders who sued the company over shares bought from the company between April 22, 2004 and May 10, 2007. Amgen Read More →
Read More →Santa Barbara’s Pensionmark adds affiliate in New York
Santa Barbara-based Pensionmark Retirement Group added an affiliate office in New York. Pensionmark is a financial retirement planning and executive compensation consulting firm. The New York-based Ridge Retirement Consultants and its team of four advisers will join the Pensionmark’s Adviser Support Program. Ridge Retirement has nearly 50 corporate clients and $1.7 billion in assets under Read More →
Read More →Citizens Business Bank second quarter net income down from 2015
CVB Financial Corp. and its subsidiary Citizens Business Bank reported $25.5 million net income for the second quarter of 2016, or 23 cents per share. That was down from $26.8 million for the second quarter of 2015, or 25 cents per share. Citizens Business Bank completed the integration of County Commerce Bank in the second Read More →
Read More →FDA declines to approve Novartis biosimilar for Amgen’s Neulasta
The Food and Drug Administration has declined for now to approve a copycat version of Amgen’s blockbuster drug Neulasta. Reuters reported July 19 that the FDA sent a letter to Swiss pharmaceutical Novartis at the end of June saying it was declining to approve the drug for now. Neulasta, made by Thousand Oaks-based biotech giant Read More →
Read More →Lockheed Martin second quarter earnings beat analyst estimates
Lockheed Martin revenues increased slightly and the company beat analyst estimates when it reported second quarter earnings results July 19. Lockheed Martin said sales increased during the quarter from $11.6 billion during the same quarter in 2015 to $12.9 billion in 2016. Earnings per share increased from $2.94 to $3.32 per share over the same Read More →
Read More →Goleta’s InTouch Health picks DeVivo to replace Wang as CEO
Goleta-based telemedicine provider InTouch Health appointed Joseph DeVivo as the new CEO to replace former CEO Dr. Yulun Wang, the company announced July 19. DeVivo was most recently the CEO of New York-based AngioDynamics, a publicly traded medical device manufacturer. He has more than 25 years of experience in the health care industry. “InTouch Health Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
